Comparative Safety Profiles of Bevacizumab, Ranibizumab and Pegaptanib in the Treatment of Age-Related Macular Degeneration: the Analysis of the WHO Database of Adverse Drug Reactions

被引：0
|
作者：
Biagi, Chiara [1 ]
Conti, Valentino [2 ]
Bonisolli, Marta [1 ]
Melis, Mauro [1 ]
Buccellato, Elena [1 ]
Covezzoli, Anna [3 ]
Amato, Roberta [3 ]
Pazzi, Linda [3 ]
Venegoni, Mauro [2 ]
Vaccheri, Alberto [1 ]
Motola, Domenico [1 ]
机构：
[1] Univ Bologna, Dept Med & Surg Sci, Pharmacol Unit, Bologna, Italy
[2] Reg Ctr Pharmacovigilance, Milan, Lombardy Region, Italy
[3] CINECA, Interuniv Consortium, Hlth Care Syst Dept, Bologna, Italy
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
522
引用
收藏
页码：276 / 276
页数：1
相关论文
共 50 条
  • [41] Systemic Vascular Safety of Ranibizumab for Age-Related Macular Degeneration
    Ueta, Takashi
    Noda, Yasuo
    Toyama, Taku
    Yamaguchi, Takuhiro
    Amano, Shiro
    OPHTHALMOLOGY, 2014, 121 (11) : 2193 - 2203
  • [42] Systemic Adverse Events after Intravitreal Bevacizumab versus Ranibizumab for Age-Related Macular Degeneration: A Meta-Analysis
    Wang, Wei
    Zhang, Xiulan
    PLOS ONE, 2014, 9 (10):
  • [43] SWITCHING TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION FROM BEVACIZUMAB TO RANIBIZUMAB Who is Likely to Benefit From the Switch?
    Moisseiev, Elad
    Katz, Gabriel
    Moisseiev, Joseph
    Loewenstein, Anat
    Goldstein, Michaella
    Lomnicky, Yosef
    Abend, Yitzhak
    Treister, Giora
    Goldenberg, Dafna
    Levkovitch-Verbin, Hana
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (07): : 1323 - 1330
  • [44] Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: A review
    Kourlas, H
    Schiller, DS
    CLINICAL THERAPEUTICS, 2006, 28 (01) : 36 - 44
  • [45] Cost effectiveness of pegaptanib for the treatment of age-related macular degeneration in the UK
    Wolowacz, Sorrel E.
    Roskell, Neil
    Kelly, Steven
    Maciver, Fiona M.
    Brand, Chris S.
    PHARMACOECONOMICS, 2007, 25 (10) : 863 - 879
  • [46] RPE tears affer pegaptanib treatment in age-related macular degeneration
    Chang, Louis K.
    Flaxel, Christina J.
    Lauer, Andreas K.
    Sarraf, David
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (07): : 857 - 863
  • [47] Anterior uveitis after treatment of age-related macular degeneration with ranibizumab and bevacizumab: uncommon complication
    Damasceno, Nadyr
    Horowitz, Soraya
    Damasceno, Eduardo
    CLINICAL OPHTHALMOLOGY, 2012, 6 : 1201 - 1205
  • [48] Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration Two-Year Results
    Martin, Daniel F.
    Maguire, Maureen G.
    Fine, Stuart L.
    Ying, Gui-shuang
    Jaffe, Glenn J.
    Grunwald, Juan E.
    Toth, Cynthia
    Redford, Maryann
    Ferris, Frederick L.
    OPHTHALMOLOGY, 2020, 127 (04) : S135 - S145
  • [49] Treatment of naive lesions in neovascular age-related macular degeneration with pegaptanib
    Quiram, Polly A.
    Hassan, Tarek S.
    Williams, George A.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (07): : 851 - 856
  • [50] Clinical experience in the treatment of neovascular age-related macular degeneration with Pegaptanib
    Maier, M.
    Feucht, N.
    Huebner, M.
    Lohmann, C.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2008, 225 (06) : 582 - 587
12345